Skip to content
DataLookout
Menu

NCT06127836

Study of Near-Infrared Imaging With Indocyanine Green for Detection of Sentinel Lymph Nodes in People With Vulvar Cancer

StatusActive, Not Recruiting
PhaseNot applicable
Primary completion (estimated)

At risk: Primary completion moved at least 11 months later.

Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 6 versions: 4 with changes below, 2 re-verified with no change. See every version on ClinicalTrials.gov ↗

  1. Notable Primary and study completion pushed from Nov 2026 to Nov 2027
    • Eligibility criteria expanded, about 8 words
  2. Minor Trial status: Recruiting to Active, Not Recruiting
    • Enrollment target: estimated 40 to confirmed 22
    • Site details revised at 8 of 8 sites
    v5
  3. Minor Study sites: 7 to 8v3
  4. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

success of identifying the SLN
Timeframe: 18 months

Arms and interventions

patients undergoing preoperative lymphoscintigraphyExperimental

Patients will undergo radiocolloid lymphoscintigraphy before their surgery; the surgeon will be blinded to the results of this procedure. The surgeon will subsequently inject ICG in accordance with the SLN protocol in the operating room and will identify and remove the SLN by use of near-infrared imaging guidance only.

Procedures: ICG guided sentinel lymph node biopsy

Sites

8 sites in 1 country